Peer Review History
| Original SubmissionJanuary 30, 2021 |
|---|
|
PONE-D-21-03081 Knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa: Systematic review and meta-analysis PLOS ONE Dear Dr. Bogale Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by 3/27/2021 If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Saeed Ahmed, MD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please confirm that you have included all items recommended in the PRISMA checklist including: - the full electronic search strategy used to identify studies with all search terms and limits for at least one database. - an explanation for why the search inclusion dates were only for the past 10 years - a Supplemental file of the results of the individual components of the quality assessment, not just the overall score, for each study included. - See https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000100#pmed-1000100-t003 for guidance on reporting. Thank you. 3. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files. 4.Thank you for stating the following financial disclosure: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." At this time, please address the following queries:
Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Partly Reviewer #5: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: I Don't Know Reviewer #4: Yes Reviewer #5: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear Authors, This is a systematic review and meta-analysis regarding the knowledge, attitude and practice towards cervical cancer screening in Africa. The study included eight published papers and found that the estimated pooled proportion of knowledge, attitudes and practices among the participants were 43%, 38% and 41% respectively. Major strength of the study was the large number of participants from the pooled review and statistical analysis. Weaknesses include only eight published papers from a large time frame which is not well described. There are quite a number of grammatical errors. I have added some of the grammatical errors and sentence formation that needs to be revised. Some areas are not clear as to what the authors are trying to convey. Line 31 To establish successful strategies and increasing the utilization of preventive services Line 38 Methods- Would help to have definite time frame- says till august 2020 but does not say from when Line 50 Conclusion: The pooled estimates of knowledge, attitude and practice were lower than other developed countries calls for further activities to enhance the uptake of the services and establish successful strategies. Line 79 When looked at the patients suffered gynecological cancer, more than half of them knew that their disease was malignant Line 80 In addition, different evidence about knowledge, attitude and practice were generated at different corners of Asian countries [9] [10] [11] [12] that seek for pooling of the findings for decision making. Line 88 On the basis of the comprehensive literature search made, variability on the KAP score prevails in various African countries assumed have high prevalence of the problem and moreover unavailability of information among the female population living with HIV who are the most vulnerable population. Line 119 In this review, we included a cross sectional studies conducted in Africa Line 120 The inclusion was restricted to papers published in the English language within a ten year period till last August 2020 Page 6- identification tab states n=131 and gives the number of articles in each database but they do not add up to 131. They only add up to 85. Line 168-170 We extracted data from eligible abstract and/or full text of the articles by considering the outcome variables and the characteristics of participants such as age range, mean or median age, sex, HIV sero-status. Line 193 Almost all included studies were cross-sectional types published from 2014 to 2019 though the extraction of data was done for the past ten years till August 2020. Reviewer #2: Study is a Systematic review and meta-analysis, with no conflict of interests from authors and no conflict from a funding perspective. Published articles were from well accepted and vetted databases in accordance with PRISMA. Authors included cross sectional studies conducted in Africa that reported Knowledge, attitude and practice towards cervical cancer screening in HIV. Study has included 131 articles based on initial screening and after applying Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies, total 8 articles were analyzed. Study, very importantly is addressing the key aspect to devise a well though out prevention strategy: the knowledge, attitude and practice (KAP) of a particular subgroup. The study goal is especially important as the group is the female population living with HIV who are the most vulnerable population. Documentation of KAP among HIV infected African women towards cervical cancer screening will have positive effects towards the goal to decrease HIV prevalence, viral suppression HIV as well as the comorbidity of Cervical Cancer. I think it was an appropriate to restrict the studies done within the last 10 years as we are trying to assess the current KAP. Minor revision Recommendations. 1. 8 studies evaluated where all healthcare facility based. It will be appropriate to know what kind of facility. For example, if all the patients were from a tertiary hospital vs rural health center, I will worry about disparity in healthcare access creating a bias on KAP. Can the authors clarify that with an additional chart? 2. Most patients were from Ethiopia and the difference in health system from different countries can affect the generalizability of the result to whole of the African Continent. Can that be clarified? If not mentioned as a concern in the discussion. 3. Study team could have included CD4 as well as AIDS terms to their search strategy key terms broadening some data collection keeping immune suppression in mind. Cervical cancer incidence correlate with a lower CD4 count. ( JAMA. 2005;293:1471–1476.) Reviewer #3: Well written paper with nice introduction, aim, and clear methodology, few points that i feel should be addressed please: - The author need to define in the methodology what they meant by knowledge, attitude and practice (KAP) - Page 2, line 42, no need to say last August 2020, August 2020 is enough - Page 3, line 70 add measures after preventive - Page 5, 2nd paragraph starting with PubMed need to be revised as it include a lot of unnecessary punctuation marks - Page 5, line 121, again no need to say last August 2020, August 2020 is enough - Page 13, line 307, again no need to say last August 2020, August 2020 is enough - The conclusion need to be more precise. Reviewer #4: - the manuscript needs some minor grammatical/language corrections. - it is hard to assess the numbers- how do you decide whether knowledge/attitude/practice is appropriate or not? what are the specific parameters you used to decide to decide whether KAP is prevalent or not. - also as expected there is lot of heterogeneity among the studies. - in the abstract, the authors have mentioned that KAP is less compared to developed nations, although in the discussion section most comparisons are made to low/middle income and developing nations. Can authors cite and compare their finding with some studies from North American/European/Developed nations Reviewer #5: This manuscript pooled results about the percentage of knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa using meta-analysis. I have below comments. The overall statistical analysis follows the routine methods of meta-analysis. There are big heterogeneities among studies. It is not necessary to calculate pooled estimates for those results. The heterogeneity may exist because different level of health care, service or education between locations. There might be other factors too. It will be informative to investigate the reason of such existing heterogeneity in knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No Reviewer #5: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa: Systematic review and meta-analysis PONE-D-21-03081R1 Dear Dr. Bogale We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Saeed Ahmed, MD Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-21-03081R1 Knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa: Systematic review and meta-analysis Dear Dr. Bogale: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Saeed Ahmed Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .